当前位置:首页 - 行情中心 - 康芝药业(300086) - 财务分析

康芝药业

(300086)

  

流通市值:23.58亿  总市值:24.35亿
流通股本:4.41亿   总股本:4.55亿

康芝药业(300086)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.10亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益115505.97万元,未分配利润-27455.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产201288.13万元,负债85782.16万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入112,416,086.22472,817,734.83363,813,064.07220,198,812.69
营业总成本126,233,165.07643,150,239.2522,876,726.08342,586,586.75
营业利润-10,056,825.06-222,347,012.53-140,561,696.09-116,661,877.13
利润总额-9,951,321.87-231,970,837.8-141,911,509.13-117,894,384.11
净利润-10,256,142.69-224,426,506.01-124,651,523.18-102,127,500.15
其他综合收益--252,137.11--
综合收益总额-10,256,142.69-224,678,643.12-124,651,523.18-102,127,500.15
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计440,262,634.94443,074,835.84522,349,018.33515,221,950.44
非流动资产合计1,572,618,695.841,532,775,713.851,565,273,119.981,570,757,802.9
资产总计2,012,881,330.781,975,850,549.692,087,622,138.312,085,979,753.34
流动负债合计514,564,761.2495,680,547.46475,690,335.69447,630,119.49
非流动负债合计343,256,862.36314,851,053.1329,643,176.11351,515,877.5
负债合计857,821,623.56810,531,600.56805,333,511.8799,145,996.99
归属于母公司股东权益合计1,130,227,617.531,139,922,413.011,250,594,836.811,254,483,543.87
股东权益合计1,155,059,707.221,165,318,949.131,282,288,626.511,286,833,756.35
负债和股东权益合计2,012,881,330.781,975,850,549.692,087,622,138.312,085,979,753.34
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计205,002,738.01753,309,627.31526,104,289.75351,461,177.24
经营活动现金流出小计164,489,600.04681,849,701.69520,809,005.54352,978,175.28
经营活动产生的现金流量净额40,513,137.9771,459,925.625,295,284.21-1,516,998.04
投资活动现金流入小计-9,843,658.036,358,946.842,000
投资活动现金流出小计73,881,504.4393,757,908.6469,924,827.1748,910,916.71
投资活动产生的现金流量净额-73,881,504.43-83,914,250.61-63,565,880.37-48,868,916.71
筹资活动现金流入小计60,503,915.74186,877,956.26137,377,956.2694,710,492.5
筹资活动现金流出小计47,349,622.12200,942,395.6599,811,508.2387,994,788.23
筹资活动产生的现金流量净额13,154,293.62-14,064,439.3937,566,448.036,715,704.27
汇率变动对现金及现金等价物的影响-3,171.4652,155.9248,785.35-
现金及现金等价物净增加额-20,217,244.3-26,466,608.46-20,655,362.78-43,670,210.48
期末现金及现金等价物余额92,968,241.64108,177,324.4123,627,683.55100,728,124.62
TOP↑